MiMedx Group: Q2 Earnings Insights

MiMedx Group (NASDAQ:MDXG) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings MiMedx Group missed estimated earnings by 83.33%, reporting an EPS of $-0.11 versus an estimate of $-0.06.

MiMedx Group (NASDAQ:MDXG) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

MiMedx Group missed estimated earnings by 83.33%, reporting an EPS of $-0.11 versus an estimate of $-0.06.

Revenue was down $1.28 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 7.33% increase in the share price the next day.

To track all earnings releases for MiMedx Group visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Outset Medical Reports Preliminary Q3 2023 Financial Results; Sees Q3 Revenue $30.4M Vs $27.8M YoY; Total Cash, Including Restricted Cash, Cash Equivalents And Short-Term Investments, Was $197M As Of Sept. 30, 2023

Conference Call Scheduled for 4:30 p.m. ETOutset Medical, Inc. (NASDAQ:OM) ("Outset" or the "Company"), today announced preliminary financial results for the third quarter ended Sept. 30, 2023, and provided updated

OM